Literature DB >> 16497570

A TNNI2 mutation in a family with distal arthrogryposis type 2B.

Antony E Shrimpton1, Joe J Hoo.   

Abstract

Linkage mapping in a three-generation family with a distal arthrogryposis (DA) phenotype intermediate between DA2A and DA1 indicated linkage to 11p15.5 but not 9p13. Follow up DNA sequencing of the TNNI2 gene detected a three base pair deletion that would be predicted to result in the deletion of a glutamic acid at codon position 167 (DeltaE167). This mutation, like the two previously described TNNI2 mutations, is located in the carboxy-terminal domain and thus supports the existence of a TNNI2 critical region sensitive to alteration that will give rise to DA. Physical examination of family members confirms the high degree of variability in expression amongst mutation carriers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16497570     DOI: 10.1016/j.ejmg.2005.06.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  10 in total

1.  Role of cardiac troponin I carboxy terminal mobile domain and linker sequence in regulating cardiac contraction.

Authors:  Nancy L Meyer; P Bryant Chase
Journal:  Arch Biochem Biophys       Date:  2016-03-10       Impact factor: 4.013

Review 2.  Thin filament proteins mutations associated with skeletal myopathies: defective regulation of muscle contraction.

Authors:  Julien Ochala
Journal:  J Mol Med (Berl)       Date:  2008-06-24       Impact factor: 4.599

3.  Spectrum of mutations that cause distal arthrogryposis types 1 and 2B.

Authors:  Anita E Beck; Margaret J McMillin; Heidi I S Gildersleeve; Phillip R Kezele; Kathryn M Shively; John C Carey; Michael Regnier; Michael J Bamshad
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

Review 4.  Skeletal myosin binding protein-C: An increasingly important regulator of striated muscle physiology.

Authors:  James W McNamara; Sakthivel Sadayappan
Journal:  Arch Biochem Biophys       Date:  2018-10-17       Impact factor: 4.013

5.  The embryonic myosin R672C mutation that underlies Freeman-Sheldon syndrome impairs cross-bridge detachment and cycling in adult skeletal muscle.

Authors:  Alice W Racca; Anita E Beck; Margaret J McMillin; F Steven Korte; Michael J Bamshad; Michael Regnier
Journal:  Hum Mol Genet       Date:  2015-03-03       Impact factor: 6.150

6.  Thick and thin filament gene mutations in striated muscle diseases.

Authors:  Homa Tajsharghi
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

7.  A gain-of-function mutation in Tnni2 impeded bone development through increasing Hif3a expression in DA2B mice.

Authors:  Xiaoquan Zhu; Fengchao Wang; Yanyang Zhao; Peng Yang; Jun Chen; Hanzi Sun; Lei Liu; Wenjun Li; Lin Pan; Yanru Guo; Zhaohui Kou; Yu Zhang; Cheng Zhou; Jiang He; Xue Zhang; Jianxin Li; Weitian Han; Jian Li; Guanghui Liu; Shaorong Gao; Ze Yang
Journal:  PLoS Genet       Date:  2014-10-23       Impact factor: 5.917

8.  Distal arthrogryposis with variable clinical expression caused by TNNI2 mutation.

Authors:  Vida Čulić; Noriko Miyake; Sunčana Janković; Davor Petrović; Marko Šimunović; Tomislav Đapić; Masaaki Shiina; Kazuhiro Ogata; Naomichi Matsumoto
Journal:  Hum Genome Var       Date:  2016-10-13

Review 9.  Sheldon-Hall syndrome.

Authors:  Reha M Toydemir; Michael J Bamshad
Journal:  Orphanet J Rare Dis       Date:  2009-03-23       Impact factor: 4.123

10.  Arthrogryposis multiplex congenital (AMC) in a three year old boy: differential diagnosis with distal arthrogryposis: a case report.

Authors:  Zoran S Gucev; Nada Pop-Jordanova; Gordana Dumalovska; Orhideja Stomnaroska; Gorgji Zafirovski; Velibor B Tasic
Journal:  Cases J       Date:  2009-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.